Business Context and Reporting Period
This Form 6-K filing by Stratasys Ltd. reports on the results of the 2013 Annual General Meeting of Shareholders held on June 21, 2013. The filing covers corporate governance actions, including board composition, director compensation, executive bonuses, and auditor re-appointment.
Key Financial Metrics
The filing text does not provide specific financial metrics such as revenue, profit, cash flow, margins, debt, or liquidity for the period ended June 30, 2013. The document focuses exclusively on shareholder voting outcomes.
Material Changes and Voting Results
Shareholders representing 77.48% of outstanding ordinary shares (30,031,832 shares) voted on eight proposals, all of which were approved:
- Board Expansion: Increased the Board of Directors from nine to ten members by adding an unclassified director.
- Director Election: Elected Ms. Ziva Patir as the new unclassified director.
- Director Compensation: Approved compensation terms for directors Edward J. Fierko, John J. McEleney, and Clifford H. Schweiter.
- Executive Equity: Approved up to four grants of options to purchase 100,000 ordinary shares each for Chairman and Chief Innovation Officer S. Scott Crump.
- Executive Bonus: Approved a cash bonus of NIS 460,000 (approximately $127,000) for CEO David Reis for performance in the year ended December 31, 2012.
- Insurance Coverage: Increased directors and officers liability insurance coverage to an aggregate maximum of $60 million, plus an additional $15 million for A-Side coverage.
- Authorized Share Capital: Increased authorized ordinary shares from 60 million to 180 million and share capital from NIS 600,000 to NIS 1,800,000.
- Auditor Re-appointment: Re-appointed Kesselman & Kesselman (PricewaterhouseCoopers) as independent auditors for the year ending December 31, 2013.
Guidance, Outlook, and Risks
The filing text does not provide management commentary, financial guidance, outlook, or specific risk factors. The document serves strictly as a report of the shareholder meeting outcomes.
Investor Verification Checklist
- Verify the impact of the increased authorized share capital (180 million shares) on potential future dilution.
- Review the specific terms of the option grants approved for S. Scott Crump in the referenced Proxy Statement.
- Confirm the details of the directors and officers liability insurance policy limits and coverage scope.
- Check the Proxy Statement (Exhibit 99.1) for detailed compensation structures for the newly elected and existing directors.